- Patent Title: Polyethylene glycol based prodrug of adrenomedullin and use thereof
-
Application No.: US14355568Application Date: 2012-10-30
-
Publication No.: US09603936B2Publication Date: 2017-03-28
- Inventor: Ingo Flamme , Johannes Köbberling , Hans-Georg Lerchen , Nils Griebenow , Rudolf Schohe-Loop , Sven Wittrock , Maria Köllnberger , Frank Wunder , Gorden Redlich , Andreas Knorr , Julie Marley , Iain Pritchard
- Applicant: Bayer Intellectual Property GmbH , BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Berlin
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Berlin
- Agent Aseem Mehta
- Priority: EP11187735 20111103
- International Application: PCT/EP2012/071507 WO 20121030
- International Announcement: WO2013/064508 WO 20130510
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K47/48 ; C07K14/575
Abstract:
The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.
Public/Granted literature
- US20140287984A1 POLYETHYLENE GLYCOL BASED PRODRUG OF ADRENOMEDULLIN AND USE THEREOF Public/Granted day:2014-09-25
Information query
IPC分类:
